Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

13:54 EDT 30th September 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 28,000+

Tuesday 30th September 2014

Dominion Diagnostics Now Offers Detection of "Z-Drugs" Commonly Prescribed for Insomnia

NORTH KINGSTOWN, R.I., Sept. 30, 2014 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and actionable clinical information, now offers a new laboratory‐based urine test for the detection of commonly prescribed Z‐Drugs. "Z‐Drugs" are a class of non‐benzodiazepine medications prescribed mainly for the treatment of insomnia. &...

Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project

WORCESTER, Mass. and TORONTO, Sept. 30, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has engaged Dr. Lakshmi P. Kotra, B. Pharm.(Hons), Ph.D., as a consultant to the Company to provide expertise and assistance in the management of the Company's previously announced buccal insulin enhancement project. In this role, Dr. Kotra will work...

UK trial suggests drug combo extends life for melanoma patients

Treating patients suffering from the deadliest form of skin cancer with a combination of drugs could help extend their lives, research has suggested.

ADC Therapeutics Expands Team

ADC Therapeutics (ADCT, a portfolio company of Auven Therapeutics) the oncology drug development company focused on Antibody Drug Conjugates (ADCs) targeting major cancers, today announced a significant expansion of its team as the Company’s first ADCs enter clinical development. New team members include: Dr Jay Feingold joins ...

BRIEF-Nemaris and Medicrea receive FDA clearance for SURGIMAP 2.0

* Announced on Monday that it has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for the SURGIMAP 2.0 platform

Otsuka gets FDA approval for dual-chamber syringe for abilify maintena to treat schizophrenia

Otsuka Pharmaceutical Development & Commercialization and Lundbeck has announced that the US Food and Drug Administration (FDA) has approved a new formulation of Abilify Maintena (aripiprazole) for extended-release injectable suspension – a pre-fil...

ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation

BUDAPEST, Hungary, September 30, 2014 /PRNewswire/ -- Fast, semi-automatic creation of Markush libraries and intuitive browsing of chemistry in documents ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, launches ChemCurator, an application to extract chemical information and generate Markush structures from documents. Markush struct...

The FemmyCycle

DEL MAR, Calif., Sept. 30, 2014 /PRNewswire/ -- FemCap Inc., www.femcap.com an innovator in medical devices for women's health announces its receipt of a patent No: US, 8,795,248 B2 dated Aug. 5, 2014. The FemmyCycle menstrual cup has also received FDA clearance in the U.S., 510(K) K121857, medical device licensure from Health Canada, and the CE in Europe. This patent is related to its m...

Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs

ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).1 Clinical treatments for opioid dependence include detoxification or maintenance treatment, which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The patterns and costs of these treatments are important ...

CSL Behring Expands Manufacturing Facility In Kankakee, Illinois To Meet Patients' Growing Needs

KING OF PRUSSIA, Pa., Sept. 30, 2014 /PRNewswire/ -- CSL Behring announced that it is set to commence operations in its newly expanded facility now that the U.S. Food & Drug Administration (FDA) has granted approval. The expansion significantly increases plasma processing and albumin production capacity in the Kankakee, Ill. facility. The new facility will use the same state-of-the-art...

China Interventional Cardiovascular Device Industry Size 2014 Market Analysis, Growth, Trends and Forecast 2017

MRR.Biz Latest Publication On"China Interventional Cardiovascular Device Industry Report,2014-2017". Browse All Cardiovascular Devices Market Research Reports at http://www.marketresearchreports.biz/category/61 Albany, NY (PRWEB) September 30, 2014 Affected by the implementation of “Regulations on the Centralized Procurement of High-value Medical Consumables”, purchase price of inte...

Cannabis Science signs drug development and laboratory services agreement with ImmunoClin

Cannabis Science a US Company specializing in cannabis formulation-based drug development and related consulting, has entered into a laboratory services agreement with ImmunoClin Corporation through its wholly-owned UK subsidiary, ImmunoClin, a healt...

Medicare Open Enrollment Is Fast Approaching -- Here's What We Know So Far

Medicare beneficiaries who want to make changes to their prescription drug plans or Medicare Advantage coverage can do so starting Oct. 15 during the Medicare's program’s annual open enrollment period. There will be somewhat fewer plans to pick from this year, but in general people will have plenty of options, experts say. And although premiums aren’t expected to rise markedly overall...

Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial that targets the less-obvious sufferers of the sexual condition: women.

Glaucoma Treatment Market 2014-2019 Global Trends & Opportunities Reviewed in New Research Report

DALLAS, September 30, 2014 /PRNewswire/ -- MarketReportsOnline.com adds Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019) research report that provides an insight into the glaucoma treatment market over the years with a special focus on major categories- pharmaceuticals and devices. The report includes detailed information on market size and share by type of drugs in glaucoma...

Par Pharmaceutical starts shipping generic version of Exforge

Par Pharmaceutical Companies, Inc. today announced that it has begun shipping all four strengths of amlodipine and valsartan tablets, the generic version of Novartis' Exforge. Par received final approval from the U.S. Food and Drug Administration for...

Sanofi opens new R&D hub in Shanghai

The French drug maker recently located its first R&D hub in Asia Pacific (AP) in Shanghai. The hub, which employs about 1,400 researchers in 12 Asia Pacific countries, integrates Sanofi's capacities in biopharmaceuticals (Sanofi Biopharma), rare dise...

Trelstar® Six-Month Dosing for Prostate Cancer Patients Launches in Canada

TORONTO and LAUSANNE, Switzerland, September 30, 2014 /PRNewswire/ -- Trelstar® (triptorelin pamoate), indicated in Canada for the palliative treatment of hormone dependent advanced prostate cancer,[1] is now available in a six-month dosing option (22.5 mg). The new dosing option eases the burden on patients, with a decreased number of injections and a low incidence of injection site pain, w...

WuXi PharmaTech Announces Appointment of William R. Keller to Board

SHANGHAI, Sept. 30, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced the appointment of William Robert Keller as an independent director on the Board of Directors. He will serve on the Strategy Committee. Mr....

GenSpera to Present Lead Drug Candidate Mipsagargin at 2nd Global Life Sciences Conference in Warsaw, Poland

SAN ANTONIO, Sept. 30, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces Craig Dionne, PhD, GenSpera's CEO, will be presenting at the upcoming 2nd Global Life Sciences Conference on October 2, 2014, in Warsaw, Poland, on the trading floor of the Warsaw Stock Exchange. The conference is sponsored by WedBush ...

Twist Bioscience Secures $10 Million Loan Facility

SAN FRANCISCO, Sept. 30, 2014 /PRNewswire/ -- Twist Bioscience today announced that it secured a loan facility of up to $10 million with Silicon Valley Bank. "We continue to advance the development of our game-changing platform and user experience that will accelerate scientific discovery as we look to rapidly deliver high-quality, low cost, high-throughput synthetic DNA to our customers,"...

Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards

SAN DIEGO, Sept. 30, 2014 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, announced today that its exVive3D™ Human Liver Model has been selected as a finalist in the Diagnostics & Research Tools category for the 2014 Most Innovative New Product Awards, sponsored b...

WholeHealth Products Announces The Discovery Of The "Autism And Fragile X" Microwell And Rapid Diagnostic Test

ANAHEIM, Calif., Sept. 30, 2014 /PRNewswire/ -- Headquartered in Anaheim, California, WholeHealth Products. (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products' line o...

Dominion Diagnostics Now Offers Detection of "Z?Drugs" Commonly Prescribed for Insomnia

NORTH KINGSTOWN, R.I., Sept. 30, 2014 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of drug testing, medication monitoring, and actionable clinical information, now offers a new laboratory‐based urine test for the detection of commonly prescribed Z‐Drugs. "Z‐Drugs" are a class of non‐benzodiazepine medications prescribed mainly for the treatment of ins...

KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511

CORALVILLE, Iowa, Sept. 30, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,816,083 to KemPharm for its patent application entitled, "Benzoic Acid, Benzoic Acid De...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks